Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Costco Finally Breaks Out: Is There Still Time to Buy?

COST shares are finally breaking out after a sluggish 2025, gaining 10% in just two weeks to start the year. Is there still time to buy?

Delta Hit Turbulence in Q4—Now Comes the Opportunity

Delta Hit Turbulence in Q4—Now Comes the Opportunity

Delta Air Lines reported strengths and plans to update its fleet in 2026. Analysts expressed concerns but quickly moved on, favoring the impact on growth.

How Concerned Should Investors Be About Palantir Stock?

How Concerned Should Investors Be About Palantir Stock?

Palantir stock has surged, but valuation, government reliance, and rising competition raise concerns that investors should assess before buying PLTR stock

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

A Fresh IPO That Long-Term Investors Shouldn’t Ignore

Aktis Oncology, which recently had its IPO, has gained substantial backing from Big Pharma mainstay Eli Lilly. Investors should take note of the biotech firm.

Power Struggle: Why Big Tech Is Buying Nuclear Stocks

Silicon Valley giants are directly funding nuclear energy infrastructure to guarantee the power needed for the next generation of artificial intelligence.

3 Underfollowed Stocks Wall Street Still Likes—And for Good Reason

With upside potential in the double-digits, companies including Movado, Nomad Foods, and Mosaic could navigate challenging markets to impress this year.

Tech Wreck or Valuation Reset? Rotating to Value in 2026

Rotating toward established value sectors provides a strategic opportunity to capture consistent dividends and capitalize on steady corporate performance.

inkl

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns

Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns

After tanking on Novo's "Wegovy Pill" release, Eli Lilly shares reversed course. See why investors may like its acquisition of Ventyx Biosciences.

JPMorgan Signals a Strong Year Ahead: Is JPM Headed for $400?

JPMorgan Signals a Strong Year Ahead: Is JPM Headed for $400?

JPMorgan CEO gets bullish on the economy, describing a convergence of positive factors expected to persist for some time.

Why Amazon’s ‘Overbought’ Signal Isn’t a Red Flag

Why Amazon’s ‘Overbought’ Signal Isn’t a Red Flag

Amazon’s overbought RSI is a signal of strength, and with earnings due towards the end of the month, there are several reasons to think this is just the start.

Why Apple Chose Google to Power the Future of AI

Why Apple Chose Google to Power the Future of AI

The strategic alliance between Apple and Alphabet to bring Gemini to the iPhone marks a pivotal shift that will define the future of artificial intelligence.

Plastic Surgery: Winners and Losers of the Proposed 10% Interest Cap

Plastic Surgery: Winners and Losers of the Proposed 10% Interest Cap

The administration's rate cap proposal is forcing a historic shift where capital flees traditional lenders to chase growth in the alternative finance sector.

Small Names, Big Impact: The Stocks Behind NVIDIA’s Rubin

Small Names, Big Impact: The Stocks Behind NVIDIA’s Rubin

Investors are pivoting to specialized suppliers that solve power and speed bottlenecks for next-generation AI infrastructure to capture higher growth potential.

America’s New Favorite EV Isn’t Tesla—and the Stock May Surprise

America’s New Favorite EV Isn’t Tesla—and the Stock May Surprise

Tesla continues to dominate EV sales. But last year, General Motors proved it can steal market share with the Chevy Equinox EV, America's third-best seller.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Established Income ETFs for a More Defensive 2026

Three income ETFs stand out for 2026 in the midst of economic and interest rate uncertainty, giving investors access to either bonds or international stocks.

5 AI Stocks Positioned to Win, No Matter What

Cross-cloud operators are well-positioned for long-term strength regardless of the GPU, cloud, or provider behind the AI.

Down 20%+, These 3 Software Stocks Are Boosting Buybacks

Management teams are signaling confidence in the future of these three software stocks. They just authorized substantial buybacks with shares down big.

Microsoft Wants to Power Retail Without Competing With It

Microsoft is using AI to enter digital commerce without competing with retailers; that's not the only reason analysts remain bullish on MSFT stock in 2026

Get all your
news in one place.

100's of premium titles.
One news app.

The Outlook for 3 Non-U.S. Chip Stocks That Soared in 2025

These three international semiconductor stocks boomed in 2025. See why the outlook on these names remains solid going forward.

Nike Insiders Are Buying—But the Downside Risk Isn’t Gone

Insiders bought Nike, but investors should think twice. Challenges and risks set the stage for another double-digit price decline, the Q34 results may trigger.

These 3 Defensive Stocks Could Help Portfolios Weather a 2026 Downturn

These three stocks offer defensive income, pricing power, and stability to help protect an investor's portfolio in uncertain markets

PriceSmart’s Base-Case Calls for $45 in Upside—Bull-Case Is Better

PriceSmart is a retail winner from 2025 that is already winning in 2026, positioned to continue driving its stock price higher as the year progresses.

Amazon Unveils Alexa+ Web—The AI Strategy Wall Street Has Waited For

Integrating advanced artificial intelligence into the Prime ecosystem creates a powerful new economic engine that strengthens long-term customer retention.

This NVIDIA Partnership Shows How Big AI Can Really Get

NVIDIA is well-positioned to dominate AI markets across industries and verticals for years to come; analysts point to a 40% upside.

Inside D-Wave’s Major Acquisition—What Changes for Investors

D-Wave's planned $550-million purchase of Quantum Circuits will give it a big leg up technologically. But the company still faces commercialization questions.

1 … 34 35 36 37

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

358,568 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play